ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.75p
   
  • Change Today:
      2.13p
  • 52 Week High: 41.50
  • 52 Week Low: 8.75
  • Currency: UK Pounds
  • Shares Issued: 57.17m
  • Volume: 4,938,866
  • Market Cap: £7.29m
  • RiskGrade: 394

ReNeuron Group Overview

ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2807.5% -1327.6%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 18.2 10.6
Pr/Book 0.7  
Latest F'cast
Revenue 53.8% 71.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ReNeuron Group Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 0.04 (20.97) (54.23)p n/a n/a n/a n/a 0.0%
31-Mar-19 0.05 (17.23) (44.11)p n/a n/a n/a n/a 0.0%
31-Mar-20 6.07 (13.86) (34.96)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.26 (13.41) (29.00)p n/a n/a n/a n/a 0.0%
31-Mar-22 0.40 (11.06) (17.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ReNeuron Group Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 0.69 (9.09) (13.30)p n/a n/a n/a n/a 0.0%
31-Mar-24 0.78 (3,186.42) (11.91)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

ReNeuron Group Company Announcements

Second Price Monitoring Extn 27-Jan-2023 11:05 RNS
Price Monitoring Extension 27-Jan-2023 11:00 RNS
Share Purchase by Chief Financial Officer 24-Jan-2023 10:55 RNS

ReNeuron Group ShareCast News

Director dealings: Reneuron CFO makes share purc... 24-Jan-2023 ShareCast
ReNeuron shares tumble after first-half results 02-Dec-2022 ShareCast
ReNeuron enters cancer therapy collaboration wit... 26-Oct-2021 ShareCast

ReNeuron Group Top Newspaper Links

Reneuron tests stem cell stroke treatment 03-Sep-2014 The Herald
ReNeuron unveils board shake-up as chairman move... 21-Jul-2011 The Scotsman
ReNeuron shares in healthy shape 04-Mar-2011 The Scotsman

Latest ReNeuron Group Director Deals

Traded Action Notifier PriceAmountValue
24-Jan-23 Buy John Hawkins 9.88p 100,000 £9,878.00
23-Jan-23 Buy Iain G Ross 9.50p 100,000 £9,500.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 12.75p
Change Today 2.13p
% Change 20.00 %
52 Week High 41.50
52 Week Low 8.75
Volume 4,938,866
Shares Issued 57.17m
Market Cap £7.29m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.48% above the market average62.48% above the market average62.48% above the market average62.48% above the market average62.48% above the market average
8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average
Price Trend
94.2% below the market average94.2% below the market average94.2% below the market average94.2% below the market average94.2% below the market average
86.89% below the sector average86.89% below the sector average86.89% below the sector average86.89% below the sector average86.89% below the sector average
Income Not Available
Growth
15.24% above the market average15.24% above the market average15.24% above the market average15.24% above the market average15.24% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for 27-Jan-2023

Time Volume / Share Price
16:35 53 @ 12.50p
16:35 168 @ 12.50p
16:35 67 @ 12.50p
16:35 40 @ 12.50p
16:35 420 @ 12.50p

Top of Page